Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

11.94%

Threshold

Crossed upwards

Timeline

Published

14.12.2018

Transaction

29.11.2018

Voting rights breakdown

Voting rights acquired11.94%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBICC00065

Beneficial owner

Frank-Jan van der Velden

Declared address

Frank-Jan van der Velden, Echteld

Ersetzt die Meldung zum Einzelaktionär zum Meldepflichtsdatum 04.09.2018 Incubation B.V. is controlled on a 50:50 basis by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Mr. Frank-Jan van der Velden, Echteld, The Netherlands and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Mr. Clemens von Bitterswijk, Ruigahuizen, The Netherlands

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kuros Biosciences AG

Kuros Biosciences AG14.12.2018TBICC00065

Disclosure summary

Frank-Jan van der Velden disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 14.12.2018, at 11.94% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

11.94%

Voting rights acquired

Voting rights acquired11.94%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

Frank-Jan van der Velden disclosed a holding in Kuros Biosciences AG, published on 14.12.2018.

Publication date14.12.2018

Transaction date29.11.2018

Issuing companyKuros Biosciences AG

Beneficial ownerFrank-Jan van der Velden

Declared addressFrank-Jan van der Velden, Echteld

CategoryGroup of shareholders

Voting rights acquired11.94%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBICC00065

Conditions

Ersetzt die Meldung zum Einzelaktionär zum Meldepflichtsdatum 04.09.2018 Incubation B.V. is controlled on a 50:50 basis by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Mr. Frank-Jan van der Velden, Echteld, The Netherlands and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Mr. Clemens von Bitterswijk, Ruigahuizen, The Netherlands

Source: SIX Exchange Regulation · Publication date: 14.12.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open